IntraNerve Neuroscience and Piramidal form strategic partnership for AI continuous EEG analysis in critical care
Summary
IntraNerve Neuroscience and Piramidal announced a strategic partnership in April 2026 to develop and deploy AI tools that rapidly analyze continuous EEG data for seizure detection, stroke identification, and brain injury monitoring in critical care settings. The partnership combines IntraNerve's clinical neurology expertise with Piramidal's AI analysis platform, aiming to make real-time EEG interpretation available in ICUs that lack dedicated neurophysiologists — the reality for most hospitals outside major academic centers.
Why it matters
Critical care EEG interpretation partnerships are proliferating in 2026 as the combination of low-cost continuous EEG hardware (Ceribell, IntraNerve) and AI interpretation software reaches clinical readiness. The IntraNerve-Piramidal partnership addresses stroke and brain injury alongside epilepsy — broadening the clinical application of AI EEG beyond the seizure detection use case that first drove adoption.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial